Exosomes derived from MSCs have been shown to dramatically increase the expression of VEGF in tumor cells by activation of ERK1/2 and p38 MAPK pathways, sustaining tumor growth, and angiogenesis [182]. The gene discussed is MAPK3; the disease is neoplasm.